Xeinadin hires Tim Halford as new Chief Commercial Officer  

Tim Halford

Date:

Category:

Share this article:

Xeinadin, one of the leading professional services firms in the UK and Ireland, has announced the appointment of Tim Halford as Chief Commercial Officer (CCO) for the firm.

Tim joins with nearly 25 years of experience in managing high-growth companies in both Private Equity and Public companies.  He joins Xeinadin from Cardtronics where he was Managing Director and responsible for generating organic growth and uncovering acquisition targets that offered significant revenue growth opportunities and ensuring their smooth integration into the business. 

At Xeinadin, Tim will be responsible for increasing the revenue of the firm as well as identifying future M&A opportunities and bringing them to fruition. 

Xeinadin is a firm of business advisory and accountancy practices in over 100 locations across the UK and Ireland that provides over 40 service lines to over 50,000 clients, predominantly small and medium-sized businesses and their owner-managers. 

Xeinadin is a fast-growing, acquisitive firm, which is one of the professional services market’s leading disrupters. The significant growth of the firm follows a significant minority investment from private equity firm Exponent earlier this year.

Derry Crowley, CEO, Xeinadin, said: “We are delighted to welcome Tim to our management team. Tim has significant experience in delivering growth in businesses and is an expert in working with private equity owners. He understands our expectations for growth and has exciting plans to help us continue our journey.”

Tim Halford, CCO, Xeinadin, said: “I’m very excited to be working with Derry and the Xeinadin team. The firm is on a rapid growth trajectory and now is a great time to join the team and help to shape the next phase of its commercial growth. My experience is aligned with the firm’s ambitions and there is a strong plan in place to lead the firm to the next level.”

Latest blogs

Nothing was found here.

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin